CARISMA THERAP (CARM)
(Delayed Data from NSDQ)
$0.82 USD
-0.03 (-2.98%)
Updated Nov 22, 2024 04:00 PM ET
After-Market: $0.82 0.00 (-0.30%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 4/7/25 |
---|---|
Current Quarter | -0.28 |
EPS Last Quarter | -0.31 |
Last EPS Surprise | 0.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.33 |
Next Year | -1.26 |
EPS (TTM) | -1.56 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 4.29M | 3.40M | 14.92M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.28 | -0.25 | -1.33 | -1.26 |
# of Estimates | 1 | 1 | 1 | 2 |
Most Recent Consensus | -0.28 | -0.25 | -1.33 | -0.99 |
High Estimate | -0.28 | -0.25 | -1.33 | -0.99 |
Low Estimate | -0.28 | -0.25 | -1.33 | -1.53 |
Year ago EPS | -0.52 | -0.46 | -2.59 | -1.33 |
Year over Year Growth Est. | 46.15% | 45.65% | 48.65% | 5.26% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.28 | -0.25 | -1.33 | -1.26 |
7 Days Ago | -0.28 | -0.25 | -1.33 | -1.26 |
30 Days Ago | -0.33 | -0.33 | -1.43 | -1.43 |
60 Days Ago | -0.33 | -0.33 | -1.43 | -1.43 |
90 Days Ago | -0.33 | -0.33 | -1.43 | -1.43 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.28 | -0.25 | -1.33 | -1.26 |
Zacks Consensus Estimate | -0.28 | -0.25 | -1.33 | -1.26 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.31 | -0.27 | -0.46 | -0.52 | NA |
Estimate | -0.31 | -0.36 | -0.37 | -0.56 | NA |
Difference | 0.00 | 0.09 | -0.09 | 0.04 | 0.01 |
Surprise | 0.00% | 25.00% | -24.32% | 7.14% | 1.96% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more